About this trial

By longitudinal, prospective research in children and adolescents with Fetal Alcohol Spectrum Disorders (FASD) and their parents to explore the beneficial effects of participating in a standardized intervention program in order to treat and reduce the consequences of early brain damage. By using elements from international programs based on psychoeducation and parent training, the investigators aim to help parents to better understand and respond to the neurodevelopmental disabilities of their children, and thereby improving behavioral problems and self-regulation deficits.

Eligibility criteria

Qualifiers

Valid information about alcohol exposure in fetal life. Exceptions to this inclusion criterion are children who have been adopted and with dysmorphic features that are consistent with full Fetal Alcohol Syndrome.

Disqualifiers

Children with known genetic syndromes, progressive brain and neuromuscular diseases or major sensory defects (blindness or deafness).

Trial design

Treatments tested in this trial

  • Program of psychoeducation of parents and professionals

Treatment groups

75 Participants
are divided into 1 treatment group

Locations

1
Sørlandet Hospital4809, Arendal Norway

Sponsors and collaborators

Sorlandet Hospital HF

Lead sponsor